Serum FGF-23 levels in the CKD progression group were significantly higher than those in the non-CKD progression group (189.05 (151.59, 282.87) pg/ml versus 230.60 (66.58, 152.68) pg/ml, P < 0.05, Fig. 1b). This evidence concerns the gene FGF23 and chronic kidney disease.